Timothy P. Coughlin, Chief Financial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 30,000 shares at $24.02 ($704K) on 2014-12-19, disclosed to the SEC on 2014-12-19.
Scheduled sale ($704k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.11 | 10,000 | $231K | 32.8% |
| 2 | $23.25 | 10,000 | $233K | 33.0% |
| 3 | $24.02 | 10,000 | $240K | 34.1% |
| Total | $23.46 avg | 30,000 | $704K | 100% |
| Filing → |
| NBIX | SELL | 2017-01-18 | $142K | — | Filing → |
| NBIX | SELL | 2017-01-12 | $152K | — | Filing → |
| FATE | BUY | 2016-11-28 | $300K | — | Filing → |